Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants
Objectives As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns. Methods The Dementia Questionnaire (DQ), which utilizes proxy‐based as...
Gespeichert in:
Veröffentlicht in: | International journal of geriatric psychiatry 2019-10, Vol.34 (10), p.1403-1411 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1411 |
---|---|
container_issue | 10 |
container_start_page | 1403 |
container_title | International journal of geriatric psychiatry |
container_volume | 34 |
creator | Gaussoin, Sarah A. Espeland, Mark A. Beavers, Daniel P. Casanova, Ramon Garcia, Katelyn R. Snively, Beverly M. Shumaker, Sally A. Wallace, Robert B. Rapp, Stephen R. |
description | Objectives
As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns.
Methods
The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS).
Results
Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect.
Conclusions
Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial. |
doi_str_mv | 10.1002/gps.5130 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6742525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2217492983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</originalsourceid><addsrcrecordid>eNp1kd1qFTEUhYMo9ngUfAIJeOPN1J1JMj83gtRahYKCeh3ys1NTZiZjMqM9dz6Cz-iTmPa09Qe8SmB9WXvtLEIeMzhkAPXzszkfSsbhDtkw6PuKsaa5SzbQdbJqag4H5EHO5wBFY919csAZcNG0zYYMr3DEaQmaxnWxccRMtV8wUe1cWEKcaPR0TvFi9_P7D6MzOqpzxpwvX2XqY6IOLV4J5X5DOpxxcgWhs05LsGHWBX9I7nk9ZHx0fW7Jp9fHH4_eVKfvTt4evTytrOAdVFIY34ta8taAaXUtHQppOsG0bJA5YXqQFljdMCs675l3DrxpGTjT2t4B35IXe995NSM6W3IkPag5hVGnnYo6qL-VKXxWZ_GratoytgzekmfXBil-WTEvagzZ4jDoCeOaVV2zVvR13_GCPv0HPY9rmsp6hSr_z6H08tvQpphzQn8bhoG6rFCVCpXco0_-DH8L3nRWgGoPfAsD7v5rpE7ef7gy_AWfDqm-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2288530130</pqid></control><display><type>article</type><title>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gaussoin, Sarah A. ; Espeland, Mark A. ; Beavers, Daniel P. ; Casanova, Ramon ; Garcia, Katelyn R. ; Snively, Beverly M. ; Shumaker, Sally A. ; Wallace, Robert B. ; Rapp, Stephen R.</creator><creatorcontrib>Gaussoin, Sarah A. ; Espeland, Mark A. ; Beavers, Daniel P. ; Casanova, Ramon ; Garcia, Katelyn R. ; Snively, Beverly M. ; Shumaker, Sally A. ; Wallace, Robert B. ; Rapp, Stephen R.</creatorcontrib><description>Objectives
As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns.
Methods
The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS).
Results
Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect.
Conclusions
Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.</description><identifier>ISSN: 0885-6230</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/gps.5130</identifier><identifier>PMID: 31034676</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Aged ; Cardiovascular diseases ; Clinical trials ; Cognition - drug effects ; Cognition - physiology ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Cognition Disorders - prevention & control ; Cognitive ability ; cognitive aging ; Dementia ; Dementia - epidemiology ; Dementia disorders ; Diabetes mellitus ; Female ; Geriatric psychiatry ; Hormone replacement therapy ; Hormone Replacement Therapy - statistics & numerical data ; Humans ; Hypertension ; Incidence ; Life span ; Menopause ; Middle Aged ; Missing data ; Post-menopause ; Risk Factors ; Surveys and Questionnaires - standards ; Womens health</subject><ispartof>International journal of geriatric psychiatry, 2019-10, Vol.34 (10), p.1403-1411</ispartof><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</citedby><cites>FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</cites><orcidid>0000-0003-0850-7888</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fgps.5130$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fgps.5130$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31034676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gaussoin, Sarah A.</creatorcontrib><creatorcontrib>Espeland, Mark A.</creatorcontrib><creatorcontrib>Beavers, Daniel P.</creatorcontrib><creatorcontrib>Casanova, Ramon</creatorcontrib><creatorcontrib>Garcia, Katelyn R.</creatorcontrib><creatorcontrib>Snively, Beverly M.</creatorcontrib><creatorcontrib>Shumaker, Sally A.</creatorcontrib><creatorcontrib>Wallace, Robert B.</creatorcontrib><creatorcontrib>Rapp, Stephen R.</creatorcontrib><title>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</title><title>International journal of geriatric psychiatry</title><addtitle>Int J Geriatr Psychiatry</addtitle><description>Objectives
As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns.
Methods
The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS).
Results
Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect.
Conclusions
Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.</description><subject>Aged</subject><subject>Cardiovascular diseases</subject><subject>Clinical trials</subject><subject>Cognition - drug effects</subject><subject>Cognition - physiology</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognition Disorders - prevention & control</subject><subject>Cognitive ability</subject><subject>cognitive aging</subject><subject>Dementia</subject><subject>Dementia - epidemiology</subject><subject>Dementia disorders</subject><subject>Diabetes mellitus</subject><subject>Female</subject><subject>Geriatric psychiatry</subject><subject>Hormone replacement therapy</subject><subject>Hormone Replacement Therapy - statistics & numerical data</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Incidence</subject><subject>Life span</subject><subject>Menopause</subject><subject>Middle Aged</subject><subject>Missing data</subject><subject>Post-menopause</subject><subject>Risk Factors</subject><subject>Surveys and Questionnaires - standards</subject><subject>Womens health</subject><issn>0885-6230</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kd1qFTEUhYMo9ngUfAIJeOPN1J1JMj83gtRahYKCeh3ys1NTZiZjMqM9dz6Cz-iTmPa09Qe8SmB9WXvtLEIeMzhkAPXzszkfSsbhDtkw6PuKsaa5SzbQdbJqag4H5EHO5wBFY919csAZcNG0zYYMr3DEaQmaxnWxccRMtV8wUe1cWEKcaPR0TvFi9_P7D6MzOqpzxpwvX2XqY6IOLV4J5X5DOpxxcgWhs05LsGHWBX9I7nk9ZHx0fW7Jp9fHH4_eVKfvTt4evTytrOAdVFIY34ta8taAaXUtHQppOsG0bJA5YXqQFljdMCs675l3DrxpGTjT2t4B35IXe995NSM6W3IkPag5hVGnnYo6qL-VKXxWZ_GratoytgzekmfXBil-WTEvagzZ4jDoCeOaVV2zVvR13_GCPv0HPY9rmsp6hSr_z6H08tvQpphzQn8bhoG6rFCVCpXco0_-DH8L3nRWgGoPfAsD7v5rpE7ef7gy_AWfDqm-</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Gaussoin, Sarah A.</creator><creator>Espeland, Mark A.</creator><creator>Beavers, Daniel P.</creator><creator>Casanova, Ramon</creator><creator>Garcia, Katelyn R.</creator><creator>Snively, Beverly M.</creator><creator>Shumaker, Sally A.</creator><creator>Wallace, Robert B.</creator><creator>Rapp, Stephen R.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0850-7888</orcidid></search><sort><creationdate>201910</creationdate><title>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</title><author>Gaussoin, Sarah A. ; Espeland, Mark A. ; Beavers, Daniel P. ; Casanova, Ramon ; Garcia, Katelyn R. ; Snively, Beverly M. ; Shumaker, Sally A. ; Wallace, Robert B. ; Rapp, Stephen R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4380-54bf942537b0b7a25de45b841a56e1d4b905c01261c48ff1fdd0fb710db7c9d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Cardiovascular diseases</topic><topic>Clinical trials</topic><topic>Cognition - drug effects</topic><topic>Cognition - physiology</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognition Disorders - prevention & control</topic><topic>Cognitive ability</topic><topic>cognitive aging</topic><topic>Dementia</topic><topic>Dementia - epidemiology</topic><topic>Dementia disorders</topic><topic>Diabetes mellitus</topic><topic>Female</topic><topic>Geriatric psychiatry</topic><topic>Hormone replacement therapy</topic><topic>Hormone Replacement Therapy - statistics & numerical data</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Incidence</topic><topic>Life span</topic><topic>Menopause</topic><topic>Middle Aged</topic><topic>Missing data</topic><topic>Post-menopause</topic><topic>Risk Factors</topic><topic>Surveys and Questionnaires - standards</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gaussoin, Sarah A.</creatorcontrib><creatorcontrib>Espeland, Mark A.</creatorcontrib><creatorcontrib>Beavers, Daniel P.</creatorcontrib><creatorcontrib>Casanova, Ramon</creatorcontrib><creatorcontrib>Garcia, Katelyn R.</creatorcontrib><creatorcontrib>Snively, Beverly M.</creatorcontrib><creatorcontrib>Shumaker, Sally A.</creatorcontrib><creatorcontrib>Wallace, Robert B.</creatorcontrib><creatorcontrib>Rapp, Stephen R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gaussoin, Sarah A.</au><au>Espeland, Mark A.</au><au>Beavers, Daniel P.</au><au>Casanova, Ramon</au><au>Garcia, Katelyn R.</au><au>Snively, Beverly M.</au><au>Shumaker, Sally A.</au><au>Wallace, Robert B.</au><au>Rapp, Stephen R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int J Geriatr Psychiatry</addtitle><date>2019-10</date><risdate>2019</risdate><volume>34</volume><issue>10</issue><spage>1403</spage><epage>1411</epage><pages>1403-1411</pages><issn>0885-6230</issn><eissn>1099-1166</eissn><abstract>Objectives
As people age and the incidence of dementia increases, studies of cognitive function continue to be of importance. Ascertaining cognitive data through different mechanisms is necessary to address missing data concerns.
Methods
The Dementia Questionnaire (DQ), which utilizes proxy‐based assessments, is a potential tool to determine cognitive status in participants no longer being followed per traditional study protocol. The DQ is currently being used in the Supplemental Case Ascertainment Protocol (SCAP), which is being conducted in an ongoing study of postmenopausal women as part of the Women's Health Initiative Memory Study (WHIMS).
Results
Ninety‐four percent of the 1260 SCAP participants were eligible because of being deceased. Those who are SCAP eligible were older, were less likely to be a minority, and were more likely to have hypertension, diabetes, and prior history of cardiovascular disease (CVD) as well as being a past or current smoker. SCAP added 109 cases of probable dementia to WHIMS. Risk factor relationships were modified upon inclusion of the SCAP cases including an attenuation of a hormone therapy effect and discovery of a hypertension effect.
Conclusions
Augmenting clinic‐based cases with proxy‐based assessments is feasible and leads to increased incident cases of dementia. When planning future clinical trials, it may be of study benefit to include a protocol of proxy‐based assessments, develop strong relationships with proxies early on in the study, and attempt to maintain this relationship throughout the lifespan of the trial.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31034676</pmid><doi>10.1002/gps.5130</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0850-7888</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-6230 |
ispartof | International journal of geriatric psychiatry, 2019-10, Vol.34 (10), p.1403-1411 |
issn | 0885-6230 1099-1166 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6742525 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Aged Cardiovascular diseases Clinical trials Cognition - drug effects Cognition - physiology Cognition Disorders - diagnosis Cognition Disorders - epidemiology Cognition Disorders - prevention & control Cognitive ability cognitive aging Dementia Dementia - epidemiology Dementia disorders Diabetes mellitus Female Geriatric psychiatry Hormone replacement therapy Hormone Replacement Therapy - statistics & numerical data Humans Hypertension Incidence Life span Menopause Middle Aged Missing data Post-menopause Risk Factors Surveys and Questionnaires - standards Womens health |
title | Dementia outcomes after addition of proxy‐based assessments for deceased or proxy‐dependent participants |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dementia%20outcomes%20after%20addition%20of%20proxy%E2%80%90based%20assessments%20for%20deceased%20or%20proxy%E2%80%90dependent%20participants&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Gaussoin,%20Sarah%20A.&rft.date=2019-10&rft.volume=34&rft.issue=10&rft.spage=1403&rft.epage=1411&rft.pages=1403-1411&rft.issn=0885-6230&rft.eissn=1099-1166&rft_id=info:doi/10.1002/gps.5130&rft_dat=%3Cproquest_pubme%3E2217492983%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2288530130&rft_id=info:pmid/31034676&rfr_iscdi=true |